Coforge shares trade firm after promoter sells 6.3% stake

On October 26, 2020, Hulst B.V, the promoter of Coforge, offloaded 3.8 million equity shares, representing 6.3 per cent stake, for Rs 878 crore on the NSE, the bulk deal data shows.

Stock brokers
The stock has rallied 102 per cent in the past six months (Photo credit: Kamlesh Pednekar)
SI Reporter Mumbai
2 min read Last Updated : Oct 27 2020 | 2:21 PM IST
Shares of Coforge moved higher by 2 per cent to Rs 2,267, bouncing back 4 per cent from the intra-day low on the National Stock Exchange (NSE) on Tuesday after promoters of the company sold 6.3 per cent equity stake at Rs 2,310 per share on Monday via open market.

The stock of information technology (IT) consulting and software company was down 1.4 per cent to Rs 2,178 in the early morning trade. In the past week, it underperformed the market by falling 15 per cent, as compared to a marginal 0.1 per cent gain in the Nifty50 index till yesterday. It hit an all-time high of Rs 2,813 on October 13, 2020.

On October 26, 2020, Hulst B.V, the promoter of Coforge, offloaded 3.8 million equity shares, representing 6.3 per cent stake, for Rs 878 crore on the NSE, the bulk deal data shows. CLICK HERE FOR BULK DEAL DATA

Post transactions, Hulst B.V holding in Coforge reduced to 64 per cent from 70.28 per cent. The names of the buyers were not ascertained immediately.

However, despite the underperformance in the past week, the stock has rallied 102 per cent in the past six months, against 27 per cent surge in the S&P BSE Sensex.

For July-September quarter (Q2FY21), Coforge had registered healthy revenue growth, up 8.1 per cent quarter-on-quarter in constant currency terms. The company saw a 180 bps increase in margins in Q2FY21, mainly led by higher utilisation and cost rationalisation. Further, improvement in license revenues from its subsidiary, ramp up of large deals, higher utilisation and cost rationalisation bode well for margins in the coming quarters, analysts at ICICI Securities said in a report.

Coforge is expected to benefit from increased investment in Cloud, AI and data. Further, the company is winning healthy deals in the BFS & insurance sector. This coupled with wallet share gain in transport and improving growth trajectory in healthcare will lead to healthy growth in revenues in the coming years. This coupled with improving margins, prompt us to have a positive view on the stock from a long term perspective. However, the recent run up in stock price factors in most positives, the brokerage firm said.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Buzzing stocksQ2 resultsMarkets

Next Story